Search Results

Showing results 41 - 50 of 2097.
Sort By: Date ▼

Why even doctors with opioid use disorder seldom get 'the gold standard' of care

September 9, 2019


While medication-assisted treatment is considered "the gold standard" for managing opioid-related substance use disorders, most state programs for health care professionals seeking to recover from opioid use disorders often deny access to such medications.

Weekly Line: More patients are looking abroad for Rx drugs. Is that safe?

September 6, 2019


Faced with rising prescription drug costs, some patientshealth insurers, and municipalities have turned to other countries where they can purchase drugs at lower prices.

HHS awards $1.8B in state grants to combat, track opioid epidemic

September 6, 2019


HHS on Wednesday announced it will award more than $1.8 billion in funding to help states and communities continue to combat the opioid epidemic and improve data collection to track progress.

In the states: Judge approves deal to complete CVS-Aetna merger, North Carolina sues Juul for allegedly targeting children, and more

September 6, 2019


American Health Line rounds up the latest health care news in the states.

Medicare paid twice for about $161M in hospice drugs, report finds

September 5, 2019


Medicare Part D in 2016 unnecessarily spent an estimated $161 million on drugs that already were covered under Medicare Part A, according to an HHS Office of Inspector General report released last week.

A drug labeling mix-up left 17 children with 'werewolf syndrome'

September 4, 2019


At least 17 children in Spain have been diagnosed with hypertrichosis, also known as "werewolf syndrome," after a drug labeling error that led parents to accidentally buy drugs for hair loss, thinking they were drugs to treat acid reflux in children.

CMS upgrades Medicare Plan Finder for the first time in a decade

September 4, 2019


CMS has launched a redesigned Medicare Plan Finder that aims to make it easier for Medicare beneficiaries to compare their coverage options.

Medicare Part D spending on MS drugs increased tenfold as prices spiked, study suggests

September 3, 2019


Rising prices for multiple sclerosis drugs drove a more than sevenfold increase in out-of-pocket costs for Medicare Part D beneficiaries over a decade, according to a study published last week in JAMA Neurology.

One family's $6M drug claim (and what it means for the future of rare diseases)

August 28, 2019


Dawn Patterson and two of her children have a rare bone disease, and the only treatment is a drug that was slated to cost $6 million a year—a high price tag that observers say is indicative of the pharmaceutical industry's growing interest in treatment for rare diseases.

Purdue Pharma is looking to settle more than 2,000 opioid lawsuits, sources say

August 28, 2019


Purdue Pharma and its owners, the Sackler family, are in discussions with state and local governments to settle more than 2,000 lawsuits filed against the company over its alleged contribution to the U.S. opioid epidemic, according to individuals familiar with the negotiations.

Results Page: [Previous] 1 2 3 4 5  ... [Next]